{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:24:21Z","timestamp":1794227061008,"version":"4.9.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.chest.2026.06.060","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:11:07Z","timestamp":1785071467000},"page":"1438-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9993-2478","authenticated-orcid":false,"given":"Mona","family":"Bafadhel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Tashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MeiLan K.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8918-7075","authenticated-orcid":false,"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2026.06.060_bib1","series-title":"Chronic obstructive pulmonary disease (COPD)","year":"2024"},{"key":"10.1016\/j.chest.2026.06.060_bib2","article-title":"Chronic obstructive pulmonary disease across three decades: trends, inequalities, and projections from the Global Burden of Disease Study 2021","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.chest.2026.06.060_bib4","series-title":"Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline NG115","year":"2019"},{"issue":"8","key":"10.1016\/j.chest.2026.06.060_bib5","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3390\/jcm9082670","article-title":"Role of type 2 inflammatory biomarkers in chronic obstructive pulmonary disease","volume":"9","author":"Oishi","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1164\/rccm.202407-1287RL","article-title":"Blood eosinophil count stability in COPD and the eosinophilic exacerbator phenotype","volume":"211","author":"Baraldi","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2026.06.060_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fmed.2019.00282","article-title":"Prevalence and baseline clinical characteristics of eosinophilic chronic obstructive pulmonary disease: a meta-analysis and systematic review","volume":"6","author":"Wu","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.chest.2026.06.060_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/COPD.S152291","article-title":"Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"10.1016\/j.chest.2026.06.060_bib9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12931-020-1279-4","article-title":"The stability of blood eosinophils in chronic obstructive pulmonary disease","volume":"21","author":"Long","year":"2020","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.chest.2026.06.060_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2017.04.027","article-title":"Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts","volume":"140","author":"Kolsum","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 review","volume":"206","author":"Singh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"9240","key":"10.1016\/j.chest.2026.06.060_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2026.06.060_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2026.06.060_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2026.06.060_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01875-2024","article-title":"Transcriptomic profiling of the airway epithelium in COPD links airway eosinophilia to type 2 inflammation and corticosteroid response","volume":"65","author":"Leung","year":"2025","journal-title":"Eur Respir J"},{"issue":"170","key":"10.1016\/j.chest.2026.06.060_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0084-2023","article-title":"How inhaled corticosteroids target inflammation in COPD","volume":"32","author":"Lea","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.chest.2026.06.060_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.chest.2026.06.060_bib20","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc\u2019h","year":"2020","journal-title":"Allergy"},{"issue":"17","key":"10.1016\/j.chest.2026.06.060_bib22","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2026.06.060_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S2213-2600(23)00298-9","article-title":"Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial","volume":"12","author":"Ramakrishnan","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00838-2020","article-title":"CanCOLD Collaborative Research Group. High eosinophil counts predict decline in FEV1: results from the CanCOLD study","volume":"57","author":"Tan","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01037-2023","article-title":"The association of blood eosinophil counts and FEV1 decline: a cohort study","volume":"63","author":"Hong","year":"2024","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2026.06.060_bib29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201912-2384PP","article-title":"Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease","volume":"202","author":"Singh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2026.06.060_bib31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/all.14661","article-title":"Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease","volume":"76","author":"Higham","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2020.1757274","article-title":"Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis","volume":"7","author":"Jabarkhil","year":"2020","journal-title":"Eur Clin Respir J"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib33","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-na\u00efve patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.chest.2026.06.060_bib34","article-title":"Blood eosinophil reference values and determinants in a representative adult population","volume":"4","author":"Abohalaka","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib46","doi-asserted-by":"crossref","first-page":"00870","DOI":"10.1183\/23120541.00870-2023","article-title":"Current smoking reduces small airway eosinophil counts in COPD","volume":"10","author":"Beech","year":"2024","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/resp.13200","article-title":"Variability of blood eosinophils as a biomarker in asthma and COPD","volume":"23","author":"Gibson","year":"2018","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.chest.2026.06.060_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.202105-1162LE","article-title":"Blood eosinophil counts in chronic obstructive pulmonary disease: adding within-day variability to the equation","volume":"205","author":"Van Rossem","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2026.06.060_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacig.2022.09.001","article-title":"Rethinking blood eosinophil counts: epidemiology, associated chronic diseases, and increased risks of cardiovascular disease","volume":"1","author":"Pongdee","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib38","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaip.2019.12.019","article-title":"Associations between individual characteristics and blood eosinophil counts in adults with asthma or COPD","volume":"8","author":"Caspard","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.chest.2026.06.060_bib39","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1513\/AnnalsATS.202010-1249OC","article-title":"A comprehensive analysis of the stability of blood eosinophil levels","volume":"18","author":"Chipps","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.chest.2026.06.060_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pop.2016.07.010","article-title":"Eosinophilia","volume":"43","author":"Kovalszki","year":"2016","journal-title":"Prim Care"},{"issue":"5","key":"10.1016\/j.chest.2026.06.060_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jleuko\/qiae153","article-title":"The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes","volume":"116","author":"Higham","year":"2024","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.chest.2026.06.060_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/COPD.S197361","article-title":"The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Choi","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.chest.2026.06.060_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jointm.2025.03.001","article-title":"The association of blood eosinophil levels with sepsis and mortality risk: an observational and Mendelian Randomization Study","volume":"5","author":"Ren","year":"2025","journal-title":"J Intensive Med"},{"issue":"17","key":"10.1016\/j.chest.2026.06.060_bib44","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2026.06.060_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5937\/jomb0-27945","article-title":"Stability of hematological analytes during 48 hours storage at three temperatures using Cell-Dyn hematology analyzer","volume":"40","author":"Unalli","year":"2021","journal-title":"J Med Biochem"},{"issue":"3","key":"10.1016\/j.chest.2026.06.060_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04522-2020","article-title":"A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial","volume":"58","author":"Bafadhel","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arbr.2019.12.021","article-title":"Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronchoneumol (Engl Ed)"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12890-020-01234-3","article-title":"The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care","volume":"20","author":"Van Rossem","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.chest.2026.06.060_bib50","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A3671","article-title":"Variability of eosinophil levels over time in chronic obstructive pulmonary disease patients within an integrated healthcare delivery system [abstract]","volume":"211","author":"Mularski","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2026.06.060_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15412555.2017.1313827","article-title":"Stability of blood eosinophil count in patients with COPD in the UK Clinical Practice Research Datalink","volume":"14","author":"Landis","year":"2017","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2026.06.060_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12376","article-title":"Prevalence and coexistence of type 2 inflammatory diseases","volume":"14","author":"Mora","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.chest.2026.06.060_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108134","article-title":"Short term exacerbation risk and exhaled nitric oxide in COPD","volume":"243","author":"Romero-Linares","year":"2025","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2026.06.060_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/15412555.2025.2579360","article-title":"IgE guided use of ICS in patients with stable COPD: a real-world observational study","volume":"22","author":"Zhou","year":"2025","journal-title":"COPD"},{"issue":"10","key":"10.1016\/j.chest.2026.06.060_bib56","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/diagnostics15101245","article-title":"the emerging biomarkers in chronic obstructive pulmonary disease: a narrative review","volume":"15","author":"Phillips","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.chest.2026.06.060_bib57","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.chest.2026.06.060_bib58","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/europace\/eur130","article-title":"Management of patients with palpitations: a position paper from the European Heart Rhythm Association","volume":"13","author":"Raviele","year":"2011","journal-title":"Europace"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226062999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226062999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:51:22Z","timestamp":1794225082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369226062999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0012369226062999"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.06.060","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}